Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Archives of General Psychiatry

• Publication date

  1986-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHPSYC.1986.01800120029007PMID 3022663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain.

  1986cited by this paper
• DBI, an anxiogenic neuropeptide found in human brain.

  1986cited by this paper
• GABA and mood disorders : experimental and clinical research

  1986cited by this paper
• Cotransmission at GABAergic synapses.

  1986cited by this paper
• Endogenous ligands for benzodiazepine recognition sites.

  1985cited by this paper
• Neuropeptide modulation of GABA receptor C1- channels.

  1985cited by this paper
• Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain.

  1985cited by this paper
• Neuropeptides in human cerebrospinal fluid.

  1985cited by this paper
• A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implications.

  1984cited by this paper
• Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors.

  1983cited by this paper
• On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta-carboline derivatives.

  1983cited by this paper
• A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, β-carbolines, and phenobarbitone

  1982cited by this paper
• Drug interactions at the GABA receptor-ionophore complex.

  1982cited by this paper
• A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.

  1981cited by this paper
• Molecular mechanisms in the receptor action of benzodiazepines.

  1979cited by this paper
• Methods for reliable longitudinal observation of behavior.

  1963cited by this paper
• Methods for Reliable Longitudinal Observation of Behavior: Development of a Method for Systematic Observation of Emotional Behavior on Psychiatric Wards

  1963cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer’s Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers

  2023cites this paper
• Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis

  2023cites this paper
• Transcriptome signature changes in the liver of a migratory passerine.

  2022cites this paper
• Endozepines and their receptors: Structure, functions and pathophysiological significance.

  2020cites this paper
• Cytoprotective and Neurotrophic Effects of Octadecaneuropeptide (ODN) in in vitro and in vivo Models of Neurodegenerative Diseases

  2020cites this paper
• Differential impacts on multiple forms of spatial and contextual memory in diazepam binding inhibitor knockout mice

  2019cites this paper
• Étude des mécanismes moléculaires associés aux effets de l'ODN sur des cellules astrogliales et microgliales soumises à un stress oxydant : impact sur le métabolisme lipidique et la mort cellulaire

  2019cites this paper
• Etude des mécanismes cellulaires et moléculaires impliqués dans les effets neuroprotecteurs du gliopeptide OctaDecaNeuropeptide (ODN) dans un model murin de la Maladie de Parkinson

  2017cites this paper
• The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery

  2015cites this paper
• Leukocyte Gene Expression in Patients with Medication Refractory Depression before and after Treatment with ECT or Isoflurane Anesthesia: A Pilot Study

  2014cites this paper
• Molecular Neurobiology of Recovery with the Twelve Steps

  2013cites this paper
• Molecular Neurobiology of Addiction Recovery

  2013cites this paper
• Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease.

  2011cites this paper
• A legacy of discovery: from monoamines to GABA.

  2011cites this paper
• Much excitement about antidepressants, DBI and c-FOS.

  2011cites this paper
• Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis.

  2011cites this paper
• Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice

  2011cites this paper
• iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease

  2008cites this paper
• Evaluation of Phenotypic Changes of Acyl-CoA Binding Protein / Diazepam Binding Inhibitor Overexpression in Transgenic Mice and Rats

  2008influential citation
• Diazepam binding inhibitor overexpression in mice causes hydrocephalus, decreases plasticity in excitatory synapses and impairs hippocampus-dependent learning.

  2007cites this paper
• Role of GABA in anxiety and depression

  2007cites this paper
• Involvement of diazepam-insensitive benzodiazepine receptors in the suppression of DOI-induced head-twitch responses in diabetic mice

  2006cites this paper
• Role of androgens and glucocorticoids in the regulation of diazepam-binding inhibitor mRNA levels in male mouse hypothalamus.

  2006cites this paper
• Abnormal benzodiazepine receptor function in the depressive-like behavior of diabetic mice.

  2005cites this paper
• Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics

  2005cites this paper
• [Diazepam-binding inhibitor].

  2005cites this paper
• Somatostatin down‐regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes

  2005cites this paper
• Diazepam binding inhibitor (DBI) reduces testosterone and estradiol levels in vivo.

  2002cites this paper
• Modification of the effects of benzodiazepines on the exploratory behaviors of mice on a hole-board by diabetes.

  2001cites this paper
• [Functional involvement of cerebral diazepam binding inhibitor (DBI) in the establishment of drug dependence].

  2001cites this paper
• Impairment of GABAergic transmission in depression: new insights from neuroimaging studies.

  2000cites this paper
• Socio-psychological stress-induced antinociception in diabetic mice

  2000cites this paper
• Benzodiazepines in perspective (II): The GABAA-Benzodiazepine Receptor Ligands

  2000cites this paper
• Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats

  1998cites this paper
• Functional involvement of benzodiazepine receptors in ethanol-induced increases of diazepam binding inhibitor (DBI) and its mRNA in the mouse brain.

  1998cites this paper
• Evaluation of endozepine‐like immunoreactivity in the frontal cortex of suicide victims

  1998cites this paper
• Acyl-CoA binding protein (ACBP) regulates acyl-CoA:cholesterol acyltransferase (ACAT) in human mononuclear phagocytes.

  1997cites this paper
• Benzodiazepine binding inhibitory activity: new supportive findings on its presence in psychiatric patients and further biochemical analyses.

  1996cites this paper
• Cerebrospinal Fluid Concentrations of Corticotropin-Releasing Hormone (CRH) and Diazepam-Binding Inhibitor (DBI) during Alcohol Withdrawal and Abstinence

  1996cites this paper
• Acyl-CoA binding proteins: Multiplicity and function

  1996cites this paper
• アルコール依存形成におけるdiazepam binding inhibitor (DBI) の変化とその意義

  1995cites this paper
• Involvement of endogenous benzodiazepine receptor ligands in brain disorders: therapeutic potential for benzodiazepine antagonists?

  1995cites this paper
• Effects of the benzodiazepine antagonist flumazenil in PTSD.

  1995cites this paper
• Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.

  1995cites this paper
• [The benzodiazepine receptor: the enigma of the endogenous ligand].

  1995cites this paper
• Increased expression of diazepam binding inhibitor in human brain tumors.

  1995cites this paper
• Psychopharmacology of benzodiazepines—an update

  1995cites this paper
• Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers.

  1994cites this paper
• EFFECT OF FLUMAZENIL ON BASAL AND NALOXONE‐STIMULATED ACTH AND CORTISOL RELEASE IN HUMANS

  1994cites this paper
• CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers.

  1994cites this paper
• The Alcohol Withdrawal Syndrome. Neurobiology of Treatment and Toxicity

  1994cites this paper
• Neurochemical correlates of sympathetic activation during severe alcohol withdrawal.

  1994cites this paper
• CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study

  1994cites this paper
• Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.

  1994cites this paper
• The NIMH Research Program in Panic Disorder: the present and future.

  1993cites this paper
• Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system.

  1993cites this paper
• Topology of two DBI receptors in human lymphocytes.

  1993cites this paper
• Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function.

  1993cites this paper
• Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

  1993cites this paper
• Neuropeptides in relation to suicidal behavior in depression.

  1993cites this paper
• Alterations in Neuropeptides in Aging and Disease

  1993cites this paper
• CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships.

  1993cites this paper
• Panic Attacks

  1992cites this paper
• Variabilität des Benzodiazepin-Rezeptors und seiner Liganden: Gegenwart und Zukunft

  1992cites this paper
• CSF diazepam-binding inhibitor concentrations in panic disorder.

  1992cites this paper
• An enquiry into the neurochemical, neuroanatomical, and electrophysiological basis of benzodiazepine-induced spatial learning deficits in the rat

  1992cites this paper
• [Psychopharmacology and clinical aspects of benzodiazepine dependence].

  1992cites this paper
• Role of DBI in brain and its posttranslational processing products in normal and abnormal behavior.

  1991cites this paper
• The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study.

  1991cites this paper
• Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables.

  1991cites this paper
• Cerebrospinal fluid diazepam binding inhibitor in depressed patients and normal controls.

  1991cites this paper
• Diazepam binding inhibitor (DBI): a peptide with multiple biological actions.

  1991cites this paper
• Cerebrospinal fluid variables among alcoholics lack seasonal variation

  1991cites this paper
• CNS Arousal Systems: Possible Role in Delirium

  1991cites this paper
• "Prolegomena" to the biology of the diazepam binding inhibitor (DBI).

  1991cites this paper
• The Di Mascio Lecture. The allosteric modulation of GABAA receptors. Seventeen years of research.

  1991cites this paper
• Mental disorders among alcoholics. Relationship to age of onset and cerebrospinal fluid neuropeptides.

  1991cites this paper
• Alcohol, the chloride ionophore and endogenous ligands for benzodiazepine receptors.

  1991cites this paper
• Quantitative evaluation of octadecaneuropeptide-like immunoreactivity in hippocampus, cortex and cerebellum of long-term isolated male Wistar rats.

  1991cites this paper
• CSF diazepam-binding inhibitor in alcoholics and normal controls.

  1990cites this paper
• Characterization of peripheral benzodiazepine receptors in human blood mononuclear cells.

  1990cites this paper
• The psychopharmacology of GABA synapses: update 1989.

  1990cites this paper
• A study of diazepam binding inhibitor (DBI) processing products in human cerebrospinal fluid and in postmortem human brain.

  1990cites this paper
• The neurochemistry of anxiety: An update

  1990cites this paper
• Cerebrospinal fluid levels of diazepam‐binding inhibitor in neurodegenerative disorders with dementia

  1990cites this paper
• A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism

  1990cites this paper
• Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder.

  1990cites this paper
• The pharmacology of human anxiety.

  1990cites this paper
• The neurochemistry of anxiety: an update.

  1990cites this paper
• Socially mediated reduction of isolation distress in rat pups is blocked by naltrexone but not by Ro 15-1788.

  1990cites this paper
• Selective Ligands for Benzodiazepine Receptors: Recent Developments

  1990cites this paper
• DBI (Diazepam Binding Inhibitor): The precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives, and clinical implications

  1990cites this paper
• Diazepam‐binding inhibitor and corticotropin‐releasing hormone in cerebrospinal fluid

  1989cites this paper
• Is diazepam an antidepressant?

  1989cites this paper
• Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy

  1989cites this paper
• CSF GABA and neuropeptides in pathological gamblers and normal controls.

  1989cites this paper
• Benzodiazepine Receptor‐Mediated Enhancement and Inhibition of Taste Reactivity, Food Choice, and Intake

  1989cites this paper
• Benzodiazepines in the treatment of alcoholism.

  1989cites this paper
• Is Diazepam an Antidepressant?

  1989cites this paper
• Endogenous ligands for high-affinity recognition sites of psychotropic drugs.

  1988cites this paper